Perioperative medication management: General principles and practical applications

Cleveland Clinic Journal of Medicine

Volumn 76, Issue SUPPL. 4, 2009, Pages

  Whinney, Christopher ^a  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG; PRESCRIPTION DRUG;

ADULT; AGED; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HERBAL MEDICINE; HUMAN; MALE; MIDDLE AGED; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; SAFETY;

ADULT; AGED; FEMALE; HERBAL MEDICINE; HUMANS; MALE; MIDDLE AGED; NONPRESCRIPTION DRUGS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PRESCRIPTION DRUGS; SAFETY;

EID: 74349128476     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.76.s4.20     Document Type: Article

References (28)

1. National patient safety goals. The Joint Commission Web site. http:// www.jointcommission.org/patientsafety/nationalpatientsafetygoals/. Accessed July 29, 2009.
2. Papadopoulos S, Cook AM. You can withdraw from that? The effects of abrupt discontinuation of medications. Orthopedics 2006; 29:413-417.
3. Marik PE, Varon J. Requirement of perioperative stress doses of corticosteroids: a systematic review of the literature. Arch Surg 2008; 143:1222-1226.
4. Kennedy JM, van Rij AM, Spears GF, Pettigrew RA, Tucker IG. Polypharmacy in a general surgical unit and consequences of drug withdrawal. Br J Clin Pharmacol 2000; 49:353-362.
5. Bell CM, Bajcar J, Bierman AS, Li P, Mamdani MM, Urbach DR. Potentially unintended discontinuation of long-term medication use after elective surgical procedures. Arch Intern Med 2006; 166:2525-2531.
6. Pass SE, Simpson RW. Discontinuation and reinstitution of medications during the perioperative period. Am J Health Syst Pharm 2004; 61:899-912.
7. Muluk V, Macpherson DS. Perioperative medication management. In: Rose BD, ed. UpToDate. Waltham, MA; 2008.
8. Connelly CS, Panush RS. Should nonsteroidal anti-inflammatory drugs be stopped before elective surgery? Arch Intern Med 1991; 151:1963-1966.
9. Robinson CM, Christie J, Malcolm-Smith N. Nonsteroidal anti-inflammatory drugs, perioperative blood loss, and transfusion requirements in elective hip arthroplasty. J Arthroplasty 1993; 8:607-610.
10. Goldenberg NA, Jacobson L, Manco-Johnson MJ. Brief communication: duration of platelet dysfunction after a 7-day course of ibuprofen. Ann Intern Med 2005; 142:506-509.
11. González-Correa JA, Arrebola MM, Martín-Salido E, Muñoz-Marin J, de la Cuesta FS, De La Cruz JP. Effects of dexibuprofen on platelet function in humans: comparison with low-dose aspirin. Anesthesiology 2007; 106:218-225.
12. Coriat P, Richer C, Douraki T, et al. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology 1994; 81:299-307.
13. Groban L, Butterworth J. Perioperative management of chronic heart failure. Anesth Analg 2006; 103:557-575.
14. Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004; 291:1720-1729.
15. Brabant SM, Bertrand M, Eyraud D, Darmon PL, Coriat P. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg 1999; 89:1388-1392.
16. Feringa HH, Bax JJ, Schouten O, Poldermans D. Protecting the heart with cardiac medication in patients with left ventricular dysfunction undergoing major noncardiac vascular surgery. Semin Cardiothorac Vasc Anesth 2006; 10:25-31.
17. Rosenman DJ, McDonald FS, Ebbert JO, Erwin PJ, LaBella M, Montori VM. Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period. J Hosp Med 2008; 3:319-325.
18. Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA 2001; 286:208-216.
19. Cui J, Garle M, Eneroth P, Björkhem I. What do commercial ginseng preparations contain? Lancet 1994; 344:134.
20. Yuan Y, Tsoi K, Hunt RH. Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding? Am J Med 2006; 119:719-727.
21. de Abajo FJ, Montero D, Rodríguez LA, Madurga M. Antidepressants and risk of upper gastrointestinal bleeding. Basic Clin Pharmacol Toxicol 2006; 98:304-310.
22. Serebruany VL. Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something? Am J Med 2006; 119:113-116.
23. Stack CG, Rogers P, Linter SP. Monoamine oxidase inhibitors and anaesthesia: a review. Br J Anaesth 1988; 60:222-227.
24. Grennan DM, Gray J, Loudon J, Fear S. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 2001; 60:214-217.
25. Subramanian V, Pollok RC, Kang JY, Kumar D. Systematic review of postoperative complications in patients with inflammatory bowel disease treated with immunomodulators. Br J Surg 2006; 93:793-799.
26. Hurbanek JG, Jaffer AK, Morra N, Karafa M, Brotman DJ. Postmenopausal hormone replacement and venous thromboembolism following hip and knee arthroplasty. Thromb Haemost 2004; 92:337-343.
27. Cohn SL. Perioperative medication management. American College of Physicians' PIER (Physicians' Information and Education Resource) Web site. http://pier.acponline.org/physicians/diseases/d835/diagnosis/d835-s3.htm l. Posted May 29, 2009. Accessed August 14, 2009.
28. O'Riordan JM, Margey RJ, Blake G, O'Connell R. Antiplatelet agents in the perioperative period. Arch Surg 2009; 144:69-76.